Pacific Biosciences Of California (PACB)

SG&A Expense Growth

7.19%

Quarterly · Period ending:

PACB logo

PACB SG&A Expense Growth

Latest reported7.19%
PACB Quarterly SG&A Growth (QoQ) (0.00% → 7.19%)
High-resolution chart · PNG

PACB sg&a expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacific Biosciences Of California SG&A Expense Growth — Quarterly
Period endingSG&A Expense Growth
7.1903%
-8.5108%
9.4923%
-14.0318%
-9.9407%
-2.3816%
-5.9388%
22.4761%
-15.7714%
-7.805%
5.9059%
7.0441%
1.8961%
-11.5215%
22.3074%
-6.2596%
-1.3868%
6.6559%
18.0788%
8.7612%
11.1749%
45.5968%
21.534%
-2.3468%
-39.3635%
50.5007%
-17.3926%
5.1512%
-3.4554%
-1.691%
48.8672%
-9.6165%
0.0603%
3.7299%
3.1895%
-10.0161%
1.5722%
17.4863%
9.24%
6.2723%
-4.4072%
-8.3594%
18.0995%
-0.0277%
0.4549%
7.7092%
1.2042%
9.8855%
-1.7158%
0.9934%
-15.7758%
14.7536%
-1.884%
-10.4508%
5.1858%
-12.2426%
-24.3834%
29.4133%
-7.4663%
15.8678%
-0.9263%
7.6692%
28.3974%
29.2671%
13.2302%
55.1822%
2.727%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.